down arrow

Gland Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
  • View on NSE | View on BSE
INR
1,802.75
114.05 (6.75%)
BSENSE

Jan 29

BSE+NSE Vol: 32.77 lacs

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,695.36
1,486.88
1,505.62
1,424.91
1,384.05
1,405.83
1,401.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,695.36
1,486.88
1,505.62
1,424.91
1,384.05
1,405.83
1,401.71
Raw Material Cost
529.89
558.43
557.36
587.57
437.38
485.88
461.65
Purchase of Finished goods
1.50
1.94
0.88
3.10
2.15
2.66
6.58
(Increase) / Decrease In Stocks
45.26
-6.56
-37.11
-102.71
23.18
86.93
96.02
Employee Cost
424.20
385.03
408.04
373.37
342.86
329.81
355.53
Power Cost
54.01
50.17
45.66
52.60
54.66
45.38
46.52
Manufacturing Expenses
0.00
0.00
0.00
-0.01
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
205.62
183.98
163.03
163.48
163.86
158.12
171.01
Total Expenditure (Excl Depreciation)
1,260.48
1,172.99
1,137.86
1,077.40
1,024.09
1,108.77
1,137.32
Operating Profit (PBDIT) excl Other Income
434.88
313.89
367.76
347.51
359.96
297.06
264.39
Other Income
63.17
84.16
57.53
44.03
58.49
59.66
51.43
Operating Profit (PBDIT)
498.05
398.05
425.29
391.54
418.45
356.72
315.82
Interest
3.93
7.82
11.50
7.45
22.82
6.11
5.62
Exceptional Items
-24.35
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
469.77
390.23
413.79
384.09
395.63
350.61
310.20
Depreciation
107.65
106.31
101.05
95.76
96.33
93.83
91.96
Profit Before Tax
362.13
283.92
312.74
288.33
299.30
256.78
218.25
Tax
100.65
100.23
97.26
101.79
94.61
93.25
74.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
261.48
183.68
215.48
186.54
204.69
163.53
143.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
261.48
183.68
215.48
186.54
204.69
163.53
143.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
261.48
183.68
215.48
186.54
204.69
163.53
143.76
Equity Capital
16.48
16.48
16.48
16.48
16.48
16.48
16.48
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
15.87
11.15
13.08
11.32
12.42
9.92
8.72
Diluted Earnings per share
15.87
11.15
13.08
11.32
12.42
9.93
8.73
Operating Profit Margin (Excl OI)
25.65%
21.11%
24.43%
24.39%
26.01%
21.13%
18.86%
Gross Profit Margin
27.71%
26.24%
27.48%
26.96%
28.58%
24.94%
22.13%
PAT Margin
15.42%
12.35%
14.31%
13.09%
14.79%
11.63%
10.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 14.02% vs -1.24% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 42.36% vs -14.76% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 38.55% vs -14.65% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -49.74% vs -32.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Gland Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,695.36
2,269.82
-574.46
-25.31%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,695.36
2,269.82
-574.46
-25.31%
Raw Material Cost
529.89
420.46
109.43
26.03%
Purchase of Finished goods
1.50
625.17
-623.67
-99.76%
(Increase) / Decrease In Stocks
45.26
-156.10
201.36
128.99%
Employee Cost
424.20
384.62
39.58
10.29%
Power Cost
54.01
0.00
54.01
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
205.62
520.20
-314.58
-60.47%
Total Expenditure (Excl Depreciation)
1,260.48
1,794.35
-533.87
-29.75%
Operating Profit (PBDIT) excl Other Income
434.88
475.47
-40.59
-8.54%
Other Income
63.17
3.12
60.05
1,924.68%
Operating Profit (PBDIT)
498.05
478.59
19.46
4.07%
Interest
3.93
32.54
-28.61
-87.92%
Exceptional Items
-24.35
0.00
-24.35
Gross Profit (PBDT)
469.77
446.05
23.72
5.32%
Depreciation
107.65
104.64
3.01
2.88%
Profit Before Tax
362.13
341.42
20.71
6.07%
Tax
100.65
90.05
10.60
11.77%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
261.48
251.37
10.11
4.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
261.48
251.37
10.11
4.02%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
7.91
-7.91
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
261.48
243.46
18.02
7.40%
Equity Capital
16.48
189.57
-173.09
-91.31%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
15.87
12.84
3.03
23.60%
Diluted Earnings per share
15.87
12.85
3.02
23.50%
Operating Profit Margin (Excl OI)
25.65%
20.95%
0.00
4.70%
Gross Profit Margin
27.71%
19.65%
0.00
8.06%
PAT Margin
15.42%
11.07%
0.00
4.35%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,695.36 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.02% vs -1.24% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 22.49% vs -10.43% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 261.48 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 42.36% vs -14.76% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 27.74% vs 6.69% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 434.88 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 38.55% vs -14.65% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 20.81% vs 1.00% in Dec 2024

Quarterly - Interest
Interest 3.93 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -49.74% vs -32.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -82.78% vs 332.20% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.65%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."